Swiss Oligonucleotide Manufacturers (2026)
The oligonucleotide market hits USD 5.42B in 2026 at 13.14% CAGR. How Swiss CDMOs like Bachem and Microsynth win therapeutic-grade contracts.
July 2026 11 min read
The oligonucleotide market hits USD 5.42B in 2026 at 13.14% CAGR. How Swiss CDMOs like Bachem and Microsynth win therapeutic-grade contracts.